Macular Degeneration Association

Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

UPDATED

Birmingham Alabama 35249

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

Huntsville Alabama 35805

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Birmingham Alabama 35294

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Birmingham Alabama 35249

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35233

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35249-6909

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Mobile Alabama 36604

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Muscle Shoals Alabama 35661

A clinical research study for the treatment of Chronic Myeloid Leukemia

Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Alaska

Anchorage Alaska 99503

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

UPDATED

Oro Valley Arizona 85755

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of EPZ-5676

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Sedona Arizona 86336

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson Arizona 85704

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson Arizona 85724-5024

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Tucson Arizona 85724

A Phase 3 clinical study for patients with AML

Tucson Arizona 85710

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Hot Springs Arkansas 71913

A clinical research study for the treatment of Chronic Myeloid Leukemia

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Jonesboro Arkansas 72401

A clinical research study for the treatment of Chronic Myeloid Leukemia

Little Rock Arkansas 72205

A clinical research study for the treatment of Chronic Myeloid Leukemia

California

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

La Jolla California 92093-5354

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

UPDATED

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

Sacramento California 95816

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

San Diego California 92123

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

UPDATED

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

UPDATED

Santa Barbara California 93105

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

UPDATED

Solvang California 93463

Patients are needed to participate in a clinical research study of Ublituximab and ibrutinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Anaheim California 92801

A clinical research study for the treatment of Chronic Myeloid Leukemia

Anaheim California 92801

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive